|
시장보고서
상품코드
2016405
스마트 인슐린 펜 시장 보고서 : 유형별, 편의성별, 적응증별, 접속성별, 최종사용자별, 지역별(2026-2034년)Smart Insulin Pens Market Report by Type, Usability, Indication, Connectivity, End User, and Region 2026-2034 |
||||||
세계의 스마트 인슐린 펜 시장 규모는 2025년에 1억 5,870만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 3억 4,820만 달러에 달하며, 2026-2034년에 CAGR 8.85%로 성장할 것으로 예측하고 있습니다.
스마트 인슐린 펜은 스마트폰 앱과 연동되는 재사용 가능한 주사 펜으로, 당뇨병 환자가 인슐린 투여를 효율적으로 관리할 수 있도록 도와주는 제품입니다. 기존 인슐린에 비해 가격이 저렴하고 사용하기 쉬우며 유용한 알림, 경고, 보고서를 제공합니다. 혈당치, 탄수화물 섭취량, 식사량, 유효 인슐린 양을 기준으로 복용량을 계산하는 데 도움이 됩니다. 또한 인슐린의 유효기간 및 보관 온도 범위 초과를 알려주어 적시에 카트리지를 교체할 수 있도록 도와줍니다. 그 결과, 스마트 인슐린 펜은 전 세계 병원, 진료소, 외래 수술 센터, 재택 요양 시설 등에서 폭넓게 활용되고 있습니다.
스마트 인슐린 펜 시장 동향:
현재, 정확한 0.5단위 투약, 투약 누락 및 잊어버림 방지, 투약 시간 및 횟수 추적 등 스마트 인슐린 펜의 장점에 대한 대중의 인식이 높아진 것이 시장을 촉진하는 주요 요인 중 하나입니다. 여기에 더해 전 세계에서 비만 증가와 고령화로 인해 당뇨병 유병률이 증가하고 있습니다. 여기에 의료 산업의 급격한 성장이 맞물려 시장 성장을 촉진하고 있습니다. 또한 주요 시장 기업은 환자에게 지능형 주사를 제공하는 메모리 및 타이머 기능을 갖춘 스마트 인슐린 펜을 도입하기 위해 연구개발(R&D) 활동에 많은 투자를 하고 있습니다. 또한 블루투스 연결형 스마트 인슐린 펜 개발에도 주력하고 있습니다. 또한 재택치료는 보다 편안하고 편리하며 개별화된 치료가 가능하므로 그 도입이 활발히 이루어지고 있습니다. 이와 더불어, 바늘 사용, 취급, 분해, 폐기시 발생하는 바늘 찔림 사고의 증가로 인해 무침 인슐린 투여 장치에 대한 수요가 증가하고 있는 것도 시장 성장을 촉진하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 스마트 인슐린 펜 시장
제6장 시장 내역 : 유형별
제7장 시장 내역 : 유저빌리티별
제8장 시장 내역 : 적응증별
제9장 시장 내역 : 접속성별
제10장 시장 내역 : 최종사용자별
제11장 시장 내역 : 지역별
제12장 SWOT 분석
제13장 밸류체인 분석
제14장 Porter's Five Forces 분석
제15장 가격 분석
제16장 경쟁 구도
KSA 26.05.07The global smart insulin pens market size reached USD 158.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 348.2 Million by 2034, exhibiting a growth rate (CAGR) of 8.85% during 2026-2034.
A smart insulin pen is a reusable injector pen with a smartphone app that facilitates patients with diabetes in managing their insulin delivery efficiently. It is more affordable, easy to use, and provides helpful reminders, alerts, and reports compared to conventional insulin. It helps calculate doses of the blood sugar level, carbohydrate amounts, meal size, and active insulin. In addition, it notifies the expiration date or exceeding the temperature range of insulin to replace the cartridge timely. As a result, smart insulin pen finds extensive applications in hospitals, clinics, ambulatory surgical centers, and home care units across the globe.
SMART INSULIN PENS MARKET TRENDS:
At present, the growing awareness among the masses about the benefits of smart insulin pens, such as delivering accurate half-unit doses, preventing skipped or missed doses, and tracking time and number of doses, represents one of the key factors driving the market. Besides this, there is a rise in the prevalence of diabetes due to the increasing obesity and geriatric population across the globe. This, along with the burgeoning healthcare industry, is strengthening the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce smart insulin pens with memory and timing function that provides intelligent injection for patients. They are also focusing on developing Bluetooth-connected smart insulin pens. Moreover, there is an increase in the adoption of home treatment as it is more comfortable, convenient, and personalized. This, coupled with the escalating demand for needle-free insulin delivery devices due to the rising needle stick injuries while using, handling, disassembling, or disposing of needles, is bolstering the growth of the market.
KEY MARKET SEGMENTATION:
Breakup by Type:
- First Generation Pens
- Second Generation Pens
Breakup by Usability:
- Prefilled
- Reusable
Breakup by Indication:
- Type 1 Diabetes
- Type 2 Diabetes
Breakup by Connectivity:
- Bluetooth
- USB
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Home Care Settings
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bigfoot Biomedical Inc., Digital Medics Pty Ltd., Emperra GmbH E-Health Technologies, Jiangsu Delfu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, pendiq GmbH and Ypsomed AG.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global smart insulin pens market in 2025?
2. What is the expected growth rate of the global smart insulin pens market during 2026-2034?
3. What are the key factors driving the global smart insulin pens market?
4. What has been the impact of COVID-19 on the global smart insulin pens market?
5. What is the breakup of the global smart insulin pens market based on the type?
6. What is the breakup of the global smart insulin pens market based on the usability?
7. What is the breakup of the global smart insulin pens market based on the end user?
8. What are the key regions in the global smart insulin pens market?
9. Who are the key players/companies in the global smart insulin pens market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Smart Insulin Pens Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 First Generation Pens
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Second Generation Pens
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Usability
- 7.1 Prefilled
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Reusable
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Indication
- 8.1 Type 1 Diabetes
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Type 2 Diabetes
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Connectivity
- 9.1 Bluetooth
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 USB
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by End User
- 10.1 Hospitals and Clinics
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Ambulatory Surgical Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Home Care Settings
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Bigfoot Biomedical Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.2 Digital Medics Pty Ltd.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.3 Emperra GmbH E-Health Technologies
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Jiangsu Delfu Medical Device Co. Ltd.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.5 Medtronic plc
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Novo Nordisk A/S
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 pendiq GmbH
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 Ypsomed AG
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.1 Bigfoot Biomedical Inc.
